AVITA Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jun '21 Jun 30, 2021
Net Income	-43.08	-48.59	-61.85	-35.38	-26.67	-26.58
Other Adjustments	0.32	-	-	-	-	-
Operating Cash Flow	-42.76	-48.59	-61.85	-35.38	-26.67	-26.58
Operating Cash Flow Growth	-	-	-	-	-	-
Long-Term Debt Issued	49.08	-	-	-	-	-
Long-Term Debt Repaid	-42.98	-	-	-	-	-
Net Long-Term Debt Issued (Repaid)	6.1	-	-	-	-	-
Financing Cash Flow	6.1	-	-	-	-	-
Net Cash Flow	-36.67	-48.59	-61.85	-35.38	-26.67	-26.58
Free Cash Flow	-42.76	-48.59	-61.85	-35.38	-26.67	-26.58
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-56.54%	-67.85%	-96.26%	-70.56%	-77.47%	-90.94%
Free Cash Flow Per Share	-28.49	-34.88	-47.79	-27.93	-21.33	-23.45
Levered Free Cash Flow	-12.18	-48.59	-61.85	-35.38	-26.67	-26.58
Unlevered Free Cash Flow	-35.24	-42.54	-56.64	-42.73	-27.54	-26.58

SEC Filings: 10-K · 10-Q